Nils Brünner
Impact in
- Cancer Research top 0.1%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research
Papers in
- Cancer Research 131
- Protease and Inhibitor Mechanisms 104
- Cancer Genomics and Diagnostics 14
- Oncology 108
- Peptidase Inhibition and Analysis 51
- HER2/EGFR in Cancer Research 14
- Cancer Cells and Metastasis 11
- Co-authors
- Hans Jørgen Nielsen (60 shared papers)Keld Danø (22 shared papers)Ib Jarle Christensen (48 shared papers)Robert Clarke (18 shared papers)Gunilla Høyer‐Hansen (18 shared papers)Ross W. Stephens (17 shared papers)Ebbe Rønne (8 shared papers)Claus Holst‐Hansen (11 shared papers)
- Journals
- Breast Cancer Research and Treatment (14 papers)European Journal of Cancer (13 papers)International Journal of Cancer (13 papers)The International Journal of Biological Markers (11 papers)Scandinavian Journal of Gastroenterology (10 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Nils Brünner
234 papers receiving 9.5k citations
Nils Brünner's Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 4.7k
- Immunology and Allergy 1.2k
- Oncology 3.1k
- Hematology 1.3k
- Genetics 500
Countries citing papers authored by Nils Brünner
This map shows the geographic impact of Nils Brünner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nils Brünner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nils Brünner more than expected).
Fields of papers citing papers by Nils Brünner
This network shows the impact of papers produced by Nils Brünner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nils Brünner. The network helps show where Nils Brünner may publish in the future.
Co-authors
The 25 scholars most cited alongside Nils Brünner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization Hit paper breakdown → | 1998 | 574 |
| 2 | 1992 | 447 | |
| 3 | The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. | 2000 | 352 |
| 4 | 2001 | 268 | |
| 5 | Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. | 1994 | 258 |
| 6 | 1994 | 184 | |
| 7 | Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. | 1993 | 164 |
| 8 | MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. | 1997 | 158 |
| 9 | 2000 | 156 | |
| 10 | Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. | 1995 | 155 |
| 11 | Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. | 2000 | 155 |
| 12 | 1996 | 132 | |
| 13 | 1999 | 129 | |
| 14 | ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. | 1997 | 129 |
| 15 | Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. | 1993 | 115 |
| 16 | 2010 | 114 | |
| 17 | 1997 | 112 | |
| 18 | Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. | 2002 | 112 |
| 19 | 1996 | 111 | |
| 20 | 2002 | 109 |
About Nils Brünner
Nils Brünner is a scholar working on Cancer Research, Oncology, Molecular Biology, Hematology and Genetics, having authored 237 papers that have together received 9.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (104 papers), Peptidase Inhibition and Analysis (51 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers), Cell Adhesion Molecules Research (30 papers), Estrogen and related hormone effects (30 papers), HER2/EGFR in Cancer Research (14 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Cancer Research (4.7k citations), Immunology and Allergy (1.2k citations), Oncology (3.1k citations), Hematology (1.3k citations) and Genetics (500 citations). Nils Brünner has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Hans Jørgen Nielsen, Keld Danø, Ib Jarle Christensen, Robert Clarke, Gunilla Høyer‐Hansen, Ross W. Stephens, Ebbe Rønne, Claus Holst‐Hansen, John A. Foekens and Mogens Spang‐Thomsen. Their work appears in journals such as Breast Cancer Research and Treatment, European Journal of Cancer, International Journal of Cancer, The International Journal of Biological Markers and Scandinavian Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.